Gu B, Kuddus R, DeLuca N A
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
Mol Cell Biol. 1995 Jul;15(7):3618-26. doi: 10.1128/MCB.15.7.3618.
Infected-cell polypeptide 4 (ICP4) of herpes simplex virus is both a transcriptional activator and a repressor. It has been previously demonstrated that both SP1-activated transcription and USF-activated transcription are repressed by ICP4 without affecting basal transcription (B. Gu, R. Rivera-Gonzalez, C. A. Smith, and N. A. DeLuca, Proc. Natl. Acad. Sci. USA 90:9528-9532, 1993; R. Rivera-Gonzalez, A. N. Imbalzano, B. Gu, and N.A. DeLuca, Virology 202:550-564, 1994). In this study, it was found that ICP4 repressed the activation function of two other activators, VP16 and ICP4 itself, in vitro. ICP4 inhibited transcription by interfering with the formation of transcription initiation complexes without affecting transcription elongation. Repression of activator function required that an ICP4 DNA binding site was present in one orientation within approximately 45 bp 3' to the TATA box. DNA binding by ICP4 was necessary but not sufficient for repression. ICP4 has been shown to form tripartite complexes cooperatively with the TATA box-binding protein and TFIIB on DNA containing an ICP4 binding site and a TATA box (C. A. Smith, P. Bates, R. Rivera-Gonzalez, B. Gu, and N. DeLuca, J. Virol. 67:4676-4687, 1993). A region of ICP4 that enables the molecule to form tripartite complexes was also required in addition to the DNA binding domain for efficient repression. Moreover, repression was observed only when the ICP4 binding site was in a position that resulted in the formation of tripartite complexes. Together, the data suggest that ICP4 represses transcription by binding to DNA in a precise way so that it may interact with the basal transcription complex and inhibit some general step involved in the function of activators. The steps or interactions involved in transcriptional activation that are inhibited by ICP4 are discussed.
单纯疱疹病毒的感染细胞多肽4(ICP4)既是一种转录激活因子,也是一种转录抑制因子。先前已经证明,SP1激活的转录和USF激活的转录都被ICP4抑制,而不影响基础转录(B. Gu、R. Rivera-Gonzalez、C. A. Smith和N. A. DeLuca,《美国国家科学院院刊》90:9528 - 9532,1993;R. Rivera-Gonzalez、A. N. Imbalzano、B. Gu和N.A. DeLuca,《病毒学》202:550 - 564,1994)。在本研究中,发现ICP4在体外抑制了另外两种激活因子VP16和ICP4自身的激活功能。ICP4通过干扰转录起始复合物的形成来抑制转录,而不影响转录延伸。激活因子功能的抑制要求在TATA框下游约45 bp内以一种方向存在一个ICP4 DNA结合位点。ICP4与DNA的结合对于抑制是必要的,但不是充分的。已证明ICP4能与TATA框结合蛋白和TFIIB在含有ICP4结合位点和TATA框的DNA上协同形成三方复合物(C. A. Smith、P. Bates、R. Rivera-Gonzalez、B. Gu和N. DeLuca,《病毒学杂志》67:4676 - 4687,1993)。除了DNA结合结构域之外,ICP4中使该分子能够形成三方复合物的一个区域对于有效抑制也是必需的。此外,只有当ICP4结合位点处于导致三方复合物形成的位置时才观察到抑制作用。总之,数据表明ICP4通过以精确的方式与DNA结合来抑制转录,从而使其可能与基础转录复合物相互作用并抑制激活因子功能中涉及的某些一般步骤。文中讨论了被ICP4抑制的转录激活中涉及的步骤或相互作用。